Status:
ACTIVE_NOT_RECRUITING
Multidisciplinary Intervention In Chronic GVHD
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Stem Cell Transplant Complications
Graft Vs Host Disease
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
This research is being done to evaluate the feasibility and efficacy of a multidisciplinary, patient-centered intervention, Horizons Program, versus minimally enhanced standard care to improve quality...
Detailed Description
This randomized research study is being conducted to see if the Horizons Program compared to usual care is manageable and effective at improving understanding of chronic GVHD and treatment, coping, an...
Eligibility Criteria
Inclusion
- adult patients (≥ 21 years) who underwent allogeneic HCT
- have moderate to severe chronic GVHD
- are currently receiving their care at the MGH Blood and Marrow Transplant Clinic
- have the ability to participate in an English language group intervention
Exclusion
- Patients with comorbid conditions or cognitive impairment that the treating clinician believes prohibits informed consent or participation in the intervention
- Vulnerable patients, defined here as prisoners and pregnant women, will not be included in the intervention
Key Trial Info
Start Date :
August 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04479995
Start Date
August 2 2020
End Date
December 1 2025
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States, 02114